107 related articles for article (PubMed ID: 19041598)
1. Clinical progress in acute myeloid leukemia. Preface.
Rowe JM
Best Pract Res Clin Haematol; 2008 Dec; 21(4):597-9. PubMed ID: 19041598
[No Abstract] [Full Text] [Related]
2. RUNX1 rearrangements in acute myeloblastic leukemia relapsing after hematopoietic stem cell transplantation.
Nadal N; Stephan JL; Cornillon J; Guyotat D; Flandrin P; Campos L
Cancer Genet Cytogenet; 2008 Jan; 180(2):168-9. PubMed ID: 18206548
[No Abstract] [Full Text] [Related]
3. FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
Ferrara F; Criscuolo C; Riccardi C; Izzo T; Pedata M; Copia C; Vicari L; Tarsitano M; Palmieri S; Pane F
Am J Hematol; 2009 Aug; 84(8):532-5. PubMed ID: 19562748
[No Abstract] [Full Text] [Related]
4. Acute myeloid leukemia in the elderly.
Ho C; Butera JN
Med Health R I; 2011 Jan; 94(1):7-9. PubMed ID: 21290987
[No Abstract] [Full Text] [Related]
5. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
Medeiros BC
J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
[No Abstract] [Full Text] [Related]
6. Allelic ratio: a marker of clonal dominance.
Meshinchi S
Blood; 2014 Nov; 124(23):3341-2. PubMed ID: 25431476
[No Abstract] [Full Text] [Related]
7. Molecular classification of acute myeloid leukemia: are we there yet?
Radich JP
J Clin Oncol; 2008 Oct; 26(28):4539-41. PubMed ID: 18559871
[No Abstract] [Full Text] [Related]
8. Molecular characterization of acute myeloid leukemia.
Döhner K; Döhner H
Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
[No Abstract] [Full Text] [Related]
9. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults.
Asbmt Position Statement
Biol Blood Marrow Transplant; 2008 Feb; 14(2):135-6. PubMed ID: 18215776
[No Abstract] [Full Text] [Related]
10. [Acute myeloid leukemia].
Watanabe R
Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
[No Abstract] [Full Text] [Related]
11. Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD.
Juncà J; Zamora L; Cabezón M; Marcè S; Nomdedéu J
Am J Clin Pathol; 2008 Oct; 130(4):644; author reply 645. PubMed ID: 18825844
[No Abstract] [Full Text] [Related]
12. Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives.
Sekeres MA
Haematologica; 2008 Dec; 93(12):1769-72. PubMed ID: 19050066
[No Abstract] [Full Text] [Related]
13. [Recent progress in the field of hematopoietic stem cell transplantation for leukemia].
Kobayashi T; Akiyama H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):351-6. PubMed ID: 19295257
[TBL] [Abstract][Full Text] [Related]
14. Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.
Lee SH; Paietta E; Racevskis J; Wiernik PH
Am J Hematol; 2009 Oct; 84(10):701-2. PubMed ID: 19714594
[No Abstract] [Full Text] [Related]
15. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V
Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?
Schuurhuis GJ; Ossenkoppele G
Expert Rev Hematol; 2010 Feb; 3(1):1-5. PubMed ID: 21082928
[No Abstract] [Full Text] [Related]
17. Investigational drugs targeting FLT3 for leukemia.
Ustun C; DeRemer DL; Jillella AP; Bhalla KN
Expert Opin Investig Drugs; 2009 Oct; 18(10):1445-56. PubMed ID: 19671038
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic stem cell transplantation in acute myelogenous leukemia].
Brinch L; Tjønnfjord G; Gedde-Dahl T; Heldal D; Holme PA; Dybedal I
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681-2; author reply 1682. PubMed ID: 18704137
[No Abstract] [Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
